Anna Nyhlén

472 total citations
11 papers, 383 citations indexed

About

Anna Nyhlén is a scholar working on Epidemiology, Pharmacology and Molecular Medicine. According to data from OpenAlex, Anna Nyhlén has authored 11 papers receiving a total of 383 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Epidemiology, 5 papers in Pharmacology and 4 papers in Molecular Medicine. Recurrent topics in Anna Nyhlén's work include Antibiotics Pharmacokinetics and Efficacy (5 papers), Antibiotic Resistance in Bacteria (4 papers) and Substance Abuse Treatment and Outcomes (4 papers). Anna Nyhlén is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (5 papers), Antibiotic Resistance in Bacteria (4 papers) and Substance Abuse Treatment and Outcomes (4 papers). Anna Nyhlén collaborates with scholars based in Sweden, Denmark and Canada. Anna Nyhlén's co-authors include Mats Fridell, Daniel Sitar, Sheryl Zelenitsky, Robert E. Ariano, J. Peter Donnelly, G. K. M. Harding, Peter Krantz, Morten Hesse, Martin Bäckström and I. Nilsson-Ehle and has published in prestigious journals such as Clinical Pharmacology & Therapeutics, BMC Psychiatry and European Journal of Clinical Microbiology & Infectious Diseases.

In The Last Decade

Anna Nyhlén

11 papers receiving 374 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anna Nyhlén Sweden 8 210 195 87 62 58 11 383
Meredith Spada United States 7 147 0.7× 114 0.6× 176 2.0× 30 0.5× 65 1.1× 18 320
Roberto Di Virgilio Italy 9 58 0.3× 54 0.3× 37 0.4× 27 0.4× 14 0.2× 26 310
Madeline King United States 8 111 0.5× 85 0.4× 132 1.5× 59 1.0× 19 0.3× 17 330
Joan Stephenson Australia 9 17 0.1× 75 0.4× 19 0.2× 57 0.9× 57 1.0× 74 381
Bojan Joksimović Bosnia and Herzegovina 9 26 0.1× 31 0.2× 10 0.1× 28 0.5× 28 0.5× 35 302
Jacqueline Schwartz Germany 10 26 0.1× 57 0.3× 5 0.1× 12 0.2× 132 2.3× 55 344
David Hale United States 5 80 0.4× 198 1.0× 6 0.1× 33 0.5× 17 0.3× 9 350
Sung Joon Shin South Korea 12 26 0.1× 26 0.1× 23 0.3× 6 0.1× 120 2.1× 51 345
Erenie Guirguis United States 7 11 0.1× 87 0.4× 16 0.2× 12 0.2× 23 0.4× 18 305
Aviva Goral Israel 11 14 0.1× 59 0.3× 6 0.1× 10 0.2× 45 0.8× 20 301

Countries citing papers authored by Anna Nyhlén

Since Specialization
Citations

This map shows the geographic impact of Anna Nyhlén's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Nyhlén with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Nyhlén more than expected).

Fields of papers citing papers by Anna Nyhlén

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna Nyhlén. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Nyhlén. The network helps show where Anna Nyhlén may publish in the future.

Co-authorship network of co-authors of Anna Nyhlén

This figure shows the co-authorship network connecting the top 25 collaborators of Anna Nyhlén. A scholar is included among the top collaborators of Anna Nyhlén based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna Nyhlén. Anna Nyhlén is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Fridell, Mats, Martin Bäckström, Morten Hesse, et al.. (2019). Prediction of psychiatric comorbidity on premature death in a cohort of patients with substance use disorders: a 42-year follow-up. BMC Psychiatry. 19(1). 150–150. 42 indexed citations
2.
3.
Nyhlén, Anna, Mats Fridell, Martin Bäckström, Morten Hesse, & Peter Krantz. (2011). Substance abuse and psychiatric co-morbidity as predictors of premature mortality in Swedish drug abusers a prospective longitudinal study 1970 - 2006. BMC Psychiatry. 11(1). 122–122. 51 indexed citations
4.
Nyhlén, Anna, Mats Fridell, Morten Hesse, & Peter Krantz. (2011). Causes of premature mortality in Swedish drug abusers: A prospective longitudinal study 1970–2006. Journal of Forensic and Legal Medicine. 18(2). 66–72. 33 indexed citations
5.
Ariano, Robert E., Sheryl Zelenitsky, Anna Nyhlén, & Daniel Sitar. (2005). An Evaluation of an Optimal Sampling Strategy for Meropenem in Febrile Neutropenics. The Journal of Clinical Pharmacology. 45(7). 832–835. 7 indexed citations
6.
Ariano, Robert E., Anna Nyhlén, J. Peter Donnelly, et al.. (2004). Pharmacokinetics and Pharmacodynamics of Meropenem in Febrile Neutropenic Patients with Bacteremia. Annals of Pharmacotherapy. 39(1). 32–38. 158 indexed citations
7.
Ariano, Robert E., Anna Nyhlén, J. Peter Donnelly, et al.. (2003). Population Pharmacokinetics of Meropenem in Febrile Neutropenics Using NPEM and Optimal Sampling Design. Clinical Pharmacology & Therapeutics. 73(2). 1 indexed citations
8.
Nyhlén, Anna, Bengt Ljungberg, I. Nilsson-Ehle, & Inga Odenholt. (2002). Postantibiotic Effect of Meropenem and Ciprofloxacin in the Presence of 5-Fluorouracil. Chemotherapy. 48(4). 182–188. 6 indexed citations
9.
Nyhlén, Anna, Bengt Ljungberg, I. Nilsson-Ehle, & Inga Odenholt. (2002). Bactericidal Effect of Combinations of Antibiotic and Antineoplastic Agents against <i>Staphylococcus aureus</i> and <i>Escherichia coli</i>. Chemotherapy. 48(2). 71–77. 29 indexed citations
10.
Nyhlén, Anna, Anders Johnsson, Peter Höglund, Bengt Ljungberg, & I. Nilsson-Ehle. (1999). Gastrointestinal Damage Induced by Cytostatic Treatment Does not Affect the Bioavailability of Co-Trimoxazole. Chemotherapy. 45(6). 399–404. 3 indexed citations
11.
Nyhlén, Anna, et al.. (1997). Pharmacokinetics of meropenem in febrile neutropenic patients. European Journal of Clinical Microbiology & Infectious Diseases. 16(11). 797–802. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Meredith Spada Breakdown of academic impact, for papers by Roberto Di Virgilio Breakdown of academic impact, for papers by Madeline King Breakdown of academic impact, for papers by Joan Stephenson Breakdown of academic impact, for papers by Bojan Joksimović Breakdown of academic impact, for papers by Jacqueline Schwartz Breakdown of academic impact, for papers by David Hale Breakdown of academic impact, for papers by Sung Joon Shin Breakdown of academic impact, for papers by Erenie Guirguis Breakdown of academic impact, for papers by Aviva Goral
Rankless by CCL
2026